Scholarlink

<p>Intrahepatic cholangiocarcinoma (ICCA), the second most prevalent primary liver cancer, is linked to a poor prognosis. However, the role of histone lactylation-related epigenetic modifications in ICCA remains poorly understood. This study aimed to identify reliable prognostic biomarkers and establish a foundation for targeted therapies. Specifically, this study integrated single-cell RNA sequencing (scRNA-seq), bulk transcriptomic data from TCGA-ICCA and GSE107943, and a curated list of histone lactylation-related genes. Cell–cell communication analysis revealed a significant CXCL12–CXCR4 interaction between apCAFs and vCAFs (<i>p</i> &lt; 0.01). Prognostic markers were identified through regression models, and a risk signature was developed and validated using ROC curves. Five genes—<i>STMN1</i>, <i>UBE2T</i>, <i>CENPF</i>, <i>C5orf34</i>, and <i>FAM72C</i>—were established as prognostic indicators. <i>FAM72C</i> exhibited a negative correlation with plasmacytoid dendritic cells (cor = − 0.355), while <i>CENPF</i> correlated negatively with mast cells (cor = − 0.386) (<i>p</i> &lt; 0.05). Drug sensitivity analysis revealed that the IC50 values of 10 candidate compounds, including AZD6482, BX.798, and Bicalutamide, exhibited significant differences between the two groups (<i>p</i> &lt; 0.05). RT-qPCR confirmed the overexpression of <i>STMN1</i>, <i>UBE2T</i>, <i>CENPF</i>, and <i>FAM72C</i> in ICCA tissues. Overall, this study highlights the significance of histone lactylation-associated prognostic genes and potential therapeutic targets in ICCA, providing insights into tumor microenvironment modulation and precision treatment approaches.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Integrative analysis of scRNA-seq and RNA-seq to investigate the prognostic value of lactylation and fibroblast-related genes in intrahepatic cholangiocarcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月20日

查看全文
  • Siheng He,
  • Lixin Liu,
  • Lu Chen,
  • Huabin Fan,
  • Feng Shao,
  • Shudan Sun,
  • Xiaowen Zhang,
  • Sheng Hu

摘要

Intrahepatic cholangiocarcinoma (ICCA), the second most prevalent primary liver cancer, is linked to a poor prognosis. However, the role of histone lactylation-related epigenetic modifications in ICCA remains poorly understood. This study aimed to identify reliable prognostic biomarkers and establish a foundation for targeted therapies. Specifically, this study integrated single-cell RNA sequencing (scRNA-seq), bulk transcriptomic data from TCGA-ICCA and GSE107943, and a curated list of histone lactylation-related genes. Cell–cell communication analysis revealed a significant CXCL12–CXCR4 interaction between apCAFs and vCAFs (p < 0.01). Prognostic markers were identified through regression models, and a risk signature was developed and validated using ROC curves. Five genes—STMN1, UBE2T, CENPF, C5orf34, and FAM72C—were established as prognostic indicators. FAM72C exhibited a negative correlation with plasmacytoid dendritic cells (cor = − 0.355), while CENPF correlated negatively with mast cells (cor = − 0.386) (p < 0.05). Drug sensitivity analysis revealed that the IC50 values of 10 candidate compounds, including AZD6482, BX.798, and Bicalutamide, exhibited significant differences between the two groups (p < 0.05). RT-qPCR confirmed the overexpression of STMN1, UBE2T, CENPF, and FAM72C in ICCA tissues. Overall, this study highlights the significance of histone lactylation-associated prognostic genes and potential therapeutic targets in ICCA, providing insights into tumor microenvironment modulation and precision treatment approaches.